AI assistant
Sending…
Applied Therapeutics, Inc. — Director's Dealing 2023
Jun 23, 2023
34263_dirs_2023-06-23_10ac03b4-fdf7-4c92-97a8-38a56da84787.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2023-06-16
Reporting Person: Thorpe Catherine (Chief Accounting Officer)
More from Applied Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Delisting Announcement
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3